Google Alert - Business

	Business Daily update ⋅ November 22, 2020
	NEWS
	Washington Post Experimental drug given to Trump to treat covid-19 wins FDA clearance Washington Post But Regeneron's antibody treatment is expected to be in short supply. Regeneron scientists work ... Flag as irrelevant
	Reuters Mnuchin clawback of Fed funds 'deeply irresponsible,' Biden team says Reuters WASHINGTON (Reuters) - U.S. Treasury Secretary Steven Mnuchin's decision to de-fund several Federal Reserve coronavirus lending programs on Dec. 31 is "deeply irresponsible," President-elect Joe Biden's transition team said on Friday, and threatens to ... Flag as irrelevant
	CNN FDA authorizes emergency use of the antibody cocktail given to Trump to treat Covid-19 CNN President Donald Trump received the therapy, called REGEN-COV2, when he was hospitalized for coronavirus. The treatment has to be infused into the bloodstream and is meant to mimic an immune response to infection. Flag as irrelevant
	The New York Times FDA Grants Emergency Authorization of Antibody Treatment Given to Trump The New York Times The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease. Flag as irrelevant
	CNBC Tech companies are lining up to go public — here's what we learned from the most recent wave of IPO filings CNBC Among the coming IPOs, DoorDash, Roblox and Affirm have gained the most from the pandemic. Airbnb is the only one in the group that's seen revenue drop, though business is picking back up. For DoorDash and Roblox, investors have to consider what the ... Flag as irrelevant
	CNBC There are some under-the-radar hurdles that could trip up the stock market into year end CNBC There are less-apparent hurdles the bulls will have to clear over the next several weeks related to the broader supply and demand for stocks. These forces included pension fund profit-taking, Tesla's index entry, new stock supply and investors' already ... Flag as irrelevant
	USA TODAY 'It's a big, scary mess': 12 million Americans to lose jobless aid after Christmas if Congress fails to act USA TODAY The holidays aren't looking bright for Jocelyn Fox, an unemployed single mother who is grappling with competing demands: trying to play teacher for her two housebound children while struggling to make ends meet, a big stressor since her jobless aid expires ... Flag as irrelevant
	Forbes American Express Has A 'Stimulus Package' For Independent Retailers: It's Small Business Saturday Forbes Small independent retailers are "doomed," said CNBC's Jim Cramer this week. The failure of Congress and the President to pass a second stimulus package puts retail further into the hands of large retailers, like Walmart, Target, Costco, Home Depot, Lowe's ... Flag as irrelevant
	Motley Fool 3 Crazy EV Stock Ideas That Just Might Work Out Motley Fool It's been an amazing year for electric-vehicle (EV) stocks, as investors have bid shares of a number of companies higher on expectations that the automotive industry is going electric. Tesla has led the charge higher, up nearly 500% for the year, but investors ... Flag as irrelevant
	CNN As Black Friday approaches, retailers lobby states to stay open CNN New York (CNN Business) Retailers forced to close down stores to customers early in the pandemic are now pushing officials to allow them to stay open on Black Friday and into the holiday shopping season, even as coronavirus cases surge across the ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback